socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150

Pricing Thousand Oaks Startup Design 150

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. Ceres said it now expects its IPO to price at between $21.00 and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

JANUARY 30, 2012

Thousand Oaks-based Ceres , which develops specialized seeds for the biofuels industry, is planning to hit the market on February 9th, according to the NASDAQ IPO calendar. Ceres recently estimated its IPO pricing at between $21.00 Ceres has applied to list as CERE on the NASDAQ Global Market. and $23.00

Thousand Oaks 153

Thousand Oaks Marketing Southern California Pricing 153

socalTECH

FEBRUARY 23, 2012

Thousand Oaks-based Ceres , the biotechnology firm developing specialized seed stocks for the biofuels industry, rose in its IPO on Wednesday, closing at $14.80 The firm priced its IPO on Tuesday evening at $13.00 per share, pricing lower than expected after a delay in its IPO. Ceres was trading around $14.85

Thousand Oaks 145

Thousand Oaks Southern California Pricing Activity 145

socalTECH

MAY 18, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking equipment, announced Monday that it has put together a portable, pre-packaged kit which is designed for deploying Wi-Fi into disaster response and temporary events. The firm said it would offer the new product online, priced starting at $3,999.

Organization 100

Organization Thousand Oaks Conference Networking 100

Xconomy

AUGUST 26, 2016

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. It was the tweet heard around the biotech world, again.

Pricing 40

Pricing Thousand Oaks Startup Research 40

socalTECH

APRIL 29, 2014

Unfortunately, those providers decided the gold leads were expensive, and decided to use a Chinese vendor which would provide them at half price. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.

Startup 262

Startup Competition Software Review UCLA 262